The Lancet Oncology

Zanidatamab, a bispecific monoclonal antibody for HER2-positive gastro-oesophageal adenocarcinoma patients: a new hope?

Pub Date : 2025-06-02 DOI: 10.1016/s1470-2045(25)00301-8 Clélia Coutzac

Millions could lose Medicaid coverage under US budget bill

Pub Date : 2025-06-02 DOI: 10.1016/s1470-2045(25)00336-5 Sharmila Devi

Zanidatamab plus chemotherapy as first-line treatment for patients with HER2-positive advanced gastro-oesophageal adenocarcinoma: primary results of a multicentre, single-arm, phase 2 study

Pub Date : 2025-06-02 DOI: 10.1016/s1470-2045(25)00287-6 Elena Elimova, Jaffer Ajani, Howard Burris, Crystal S Denlinger, Syma Iqbal, Yoon-Koo Kang, Jwa Hoon Kim, Keun-Wook Lee, Bruce Lin, Rutika Mehta, Do-Youn Oh, Sun Young Rha, Young Mi Seol, Lin Yang, Mark A Ozog, Phillip M Garfin, Geoffrey Ku